These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32919422)

  • 1. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
    Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.
    Bagni K; Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Hansen CP; Preus Hasselby J; Holländer NH; Nissen M; Bjerregaard JK; Pfeiffer P; Yilmaz MK; Rasmussen LS; Nielsen SE; Johansen JS
    Eur J Cancer Care (Engl); 2020 May; 29(3):e13219. PubMed ID: 31908093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index does not affect the survival of pancreatic cancer patients.
    Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
    World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Cancer: Multicenter Prospective Data Collection and Analysis by the Hungarian Pancreatic Study Group.
    Lakatos G; Balázs A; Kui B; Gódi S; Szücs Á; Szentesi A; Szentkereszty Z; Szmola R; Kelemen D; Papp R; Vincze Á; Czimmer J; Pár G; Bajor J; Szabó I; Izbéki F; Halász A; Leindler L; Farkas G; Takács T; Czakó L; Szepes Z; Hegyi P; Kahán Z
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):219-25. PubMed ID: 27308654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.
    Chen Q; Ning Z; Wang L; Ying H; Dong S; Zhang C; Shen X; Guo Y; Chen H; Zhu X; Shen Y; Shi W; Hua Y; Wang K; Lin J; Xu L; Chen L; Feng L; Zhang X; Xie J; Sun B; Sun Y; Gu W; Kang M; Tang Z; Chen Z; Chen Z; Liu L; Yu J; Li Z; Meng Z
    Oncotarget; 2016 Dec; 7(51):85603-85612. PubMed ID: 27811354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifiable and non-modifiable risk factors for pancreatic cancer: A review.
    Midha S; Chawla S; Garg PK
    Cancer Lett; 2016 Oct; 381(1):269-77. PubMed ID: 27461582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
    Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
    Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathologic features of familial pancreatic cancer.
    Humphris JL; Johns AL; Simpson SH; Cowley MJ; Pajic M; Chang DK; Nagrial AM; Chin VT; Chantrill LA; Pinese M; Mead RS; Gill AJ; Samra JS; Kench JG; Musgrove EA; Tucker KM; Spigelman AD; Waddell N; Grimmond SM; Biankin AV;
    Cancer; 2014 Dec; 120(23):3669-75. PubMed ID: 25313458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
    Sheikh M; Masoudi S; Bakhshandeh R; Moayyedkazemi A; Zamani F; Nikfam S; Mansouri M; Shishavan NG; Nikeghbalian S; Brennan P; Malekzadeh R; Pourshams A
    PLoS One; 2020; 15(12):e0243511. PubMed ID: 33275621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset pancreatic malignancies: Clinical characteristics and survival associations.
    Beeghly-Fadiel A; Luu HN; Du L; Shi C; McGavic DP; Parikh AA; Raskin L
    Int J Cancer; 2016 Nov; 139(10):2169-77. PubMed ID: 27416564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial pancreatic cancer.
    Rieder H; Bartsch DK
    Fam Cancer; 2004; 3(1):69-74. PubMed ID: 15131409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China.
    Ben Q; Li Z; Liu C; Cai Q; Yuan Y; Wang K; Xiao L; Gao J; Zhang H
    Pancreas; 2012 Apr; 41(3):435-40. PubMed ID: 22422136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic delay does not influence survival of pancreatic cancer patients.
    Stornello C; Archibugi L; Stigliano S; Vanella G; Graglia B; Capalbo C; Nigri G; Capurso G
    United European Gastroenterol J; 2020 Feb; 8(1):81-90. PubMed ID: 32213057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma.
    Del Chiaro M; Zerbi A; Falconi M; Bertacca L; Polese M; Sartori N; Boggi U; Casari G; Longoni BM; Salvia R; Caligo MA; Di Carlo V; Pederzoli P; Presciuttini S; Mosca F
    Pancreatology; 2007; 7(5-6):459-69. PubMed ID: 17912010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
    Stotz M; Eisner F; Szkandera J; Absenger G; Kornprat P; Lackner C; Samonigg H; Gerger A; Pichler M
    J Clin Pathol; 2013 Sep; 66(9):753-7. PubMed ID: 23750038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
    Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
    JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.